Buscar en
Colombian Journal of Anesthesiology
Toda la web
Inicio Colombian Journal of Anesthesiology Perioperative management of massive hemoptysis during flexible bronchoscopy: Cas...
Información de la revista
Vol. 45. Núm. 3.
Páginas 256-261 (Julio - Septiembre 2017)
Vol. 45. Núm. 3.
Páginas 256-261 (Julio - Septiembre 2017)
Case report
Open Access
Perioperative management of massive hemoptysis during flexible bronchoscopy: Case report
Manejo perioperatorio de hemoptisis masiva durante la realización de fibrobroncoscopia: Reporte de caso
Juan Camilo Segura-Salgueroa,b,
Autor para correspondencia

Corresponding author at: Department of Anesthesiology, Hospital Universitario San Ignacio, Carrera 7 No. 40-62, Bogotá, Colombia.
, Lorena Díaz-Bohadac, Juan Ricardo Lutz-Peñad, Adriana Maria Posadaa, Vivian Ronderosa
a Obstructive Sleep Apnea Study Group, School of Medicine, Pontificia Universidad Javeriana, Bogotá D.C., Colombia
b Physician, Pontificia Universidad Javeriana, Bogotá D.C., Colombia
c Anesthesiologist, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá D.C., Colombia
d Internist-Pulmonologist, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá D.C., Colombia
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Texto completo
Descargar PDF
Figuras (4)
Mostrar másMostrar menos
Tablas (1)
Table 1. Arterial blood gasses.

Flexible bronchoscopy is a diagnostic or therapeutic procedure with a low incidence of complications (0.08–6.8%). Bleeding after transbronchial biopsy is a rare complication (0–2.8% of the cases), usually resulting in minor bleeding that resolves with local measures. There is no clear definition of massive hemoptysis and due to the low incidence of this condition, there are no practical guidelines for the treatment of this complication that may be catastrophic. This case discusses the occurrence of massive hemoptysis during a transbronchial biopsy under flexible bronchoscopy, including a literature review on perioperative management.

Perioperative period
Radiology interventional

La broncoscopia flexible es un procedimiento diagnóstico o terapéutico con baja incidencia de complicaciones (0.08% – 6.8%). El sangrado por biopsia transbronquial es una complicación rara (0-2,8% de los casos), suele ser leve y resuelve con medidas locales. No existe una definición clara de hemoptisis masiva y por su baja incidencia no hay guías de práctica clínica para el tratamiento de esta complicación que puede ser catastrófica. Presentamos un caso de hemoptisis masiva durante la realización de una broncoscopia flexible más biopsia transbronquial y revisamos la literatura acerca del manejo intraoperatorio.

Palabras clave:
Periodo perioperatorio
Radiologia intervencional
Texto completo

Flexible bronchoscopy is one of the most frequent procedures used in the diagnosis and/or treatment of the airway and parenchymal lung disease. The incidence of complications is 0.08–6.8%.1–7

Mild bleeding is a complication that presents one or two days after the procedure and resolves spontaneously. It is more frequent in patients receiving antiplatelet or anticoagulant therapy, or with coagulopathy. Bleeding during transbronchial biopsy occurs in up to 2.8% of the cases and usually resolves with local measures (frozen saline solution).1

Intravenous and/or local anesthetic agents inhibit the cough reflex and increase the risk of respiratory depression. The volume of bleeding in the airway alters the ventilation/perfusion ratio and increases the risk of hypoxemic respiratory failure.8

There is no precise definition of massive hemoptysis with volumes between 100ml and 1000ml in 24h,9–12 and it has been suggested to use the level of functionality affected as a result of bleeding.11 Some authors include in the definition the need for blood products, hypoxemic respiratory failure, and/or hemodynamic instability, inter alia.12–16

As a result of the low incidence of massive hemoptysis, there are no practical clinical guidelines on the management of the condition during bronchoscopy.17 We present a case of massive hemoptysis following flexible bronchoscopy transbronchial biopsy.

Case report

34-Year old patient with a history of HIV and non-compliant to medical therapy is being treated for meningeal cryptococcosis. The patient presents with respiratory symptoms with signs of alveolar occupation in the chest images and suspect opportunistic microorganism infection. The patient is scheduled for flexible bronchoscopy (FBC), bronchoalveolar lavage, and transbronchial biopsy. Functional class II/IV (NYHA scale). The physical examination rendered no positive findings and the clotting times and CBC were normal.

Basic monitoring and hemodynamic behavior are shown in Fig. 1. The induction of anesthesia was done with fentanyl (150μg [IV]), propofol (150mg IV), and succinylcholine (50mg IV), with placement of laryngeal mask # 5. Maintenance with continuous infusion of fentanyl and propofol.

Fig. 1.

Hemodynamic performance during the procedure. Red arrow: start of bleeding following transbronchial biopsy and placement of left double lumen tube. HR: heart rate, SpO2: peripheral oxygen saturation, EtCO2: end tidal CO2.

Source: Medical record (informed consent).

When undergoing a transbronchial biopsy (Fig. 1) the patient presents with bleeding and subsequent desaturation, bradycardia, and hypotension. Atropine 1mg IV and Etilefrine 3mg IV were administered. The catheter was placed in the radial artery. A left dual lumen tube was placed blindly and checked with fluoroscopy. 2cc were administered to the pneumoplugger (hemoptysis prevents visualization using the fibrobronchoscope); protective one-lung ventilation was initiated (based on patient's body weight) with subsequent SpO2 77% and FiO2 100%. Alveolar recruitment maneuvers were initiated, H2O airway pressure 57cm, two-lung ventilation was then started with tidal volume 475ml, respiratory rate 20, inspiration:expiration ratio 1:2, positive end expiratory pressure 10cm H2O, FiO2 100%, maximal and plateau inspiratory pressure 66 and 23cm H2O, respectively, despite neuromuscular relaxation.

The fibrobronchoscopy failed to identify the bleeding site. The patient presented persistent hypotension and Norepinephrine vasopressor support was initiated resulting in hemodynamic stability. The arterial blood gases (Table 1) evidenced respiratory acidosis, hemoglobin of 4.4g/dl, and hematocrit 13%. The approximate estimate of intraoperative hemorrhage was 1300cc, so the decision was made to transfuse 2 units or red blood cells. The post-transfusion thromboelastography reported R: 6.1min, K: 3.6min, angle 46.5°, MA: 57.1mm, IC: −2.6 interpreted as normal. Based on the patient's comorbidities, the decision was made not to transfuse other blood products.

Table 1.

Arterial blood gasses.

  pH  pCO2 (mmHg)  pO2 (mmHg)  HCO3 (mmol/L)  BE (mmol/L)  SaO2 (%)  Lactic acid (mmol/L) 
Intraoperative  6.9  80  115  19  −12  95%  – 
ICU admission  7.25  40  94  19.3  −7.9  96%  1.9 

BE: base excess, SaO2: oxygen saturation.

Source: Medical record (informed consent).

Arteriography under Interventional Radiology evidenced severe vasospasm at the bleeding site and thus the embolization was deferred (Fig. 2).

Fig. 2.

Aortogram and bronchial arteriography. The arteriography enables the selective catheterization of all the bilateral intercostal trunks above and below the left tracheobronchial angle, with failure to catheterize the bronchial artery. This is suggestive of vasospasm and is consistent with the arrest of the active bleeding. The hemorrhage is not visible in the aortogram. Dual lumen tube in the left source bronchus.

Source: Medical record (informed consent).

A portable chest X-ray confirms the position of the dual lumen tube and the bleeding in the left lung (Fig. 3). The patient was transferred to the ICU with stable vital signs, arterial blood gasses monitoring, improved respiratory acidosis, normal lactic acid, normal clotting times, hemoglobin 10.8g/dl, hematocrit 34%, manual platelet count 69,000, suggestive of potential intraoperative hemodilution, with normal MA. The decision was made to defer platelet transfusion.

Fig. 3.

Chest X-ray following the procedure.

Source: Medical record (informed consent).

The objective of managing a massive hemoptysis during fibrobronchoscopy is threefold: hemodynamic stability, lung isolation, and bleeding control.17Fig. 4 illustrates the algorithm suggested for massive hemoptysis management.

Fig. 4.

Algorithm proposed for the management of massive hemoptysis during fibrobronchoscopy. *With rigid fibrobronchoscope (FB) if proximal bleeding is suspected or flexible FB if the bleeding is distal. NSS: normal saline solution. Mild hemoptysis: no hemodynamic involvement and self-limiting bleeding. Severe hemoptysis: causes hemodynamic instability, requires transfusion, or results in hypoxemic respiratory failure.

Source: the authors.

Any large volume of blood loss must be quickly replaced in order to avoid tissue ischemia, irreversible shock, and multiple organ failure. The use of crystalloids is the first line of therapy; colloids have failed to show improved outcomes in mortality, multiple organ failure, length of ICU or hospital stay, number of days on mechanical ventilation, or renal replacement therapy required.18 In our case we used Ringer Lactate because the NSS is associated with hyperchloremia and metabolic acidosis.19,20

Immediate massive transfusion shall be considered in case of uncontrolled hemorrhage and hemodynamic instability, defined as the use of more than 10 units over the first 24h, more than 4 units in 1h or volume replacement of over 50% of volemia over 3h.21–23

The massive transfusion protocols with fixed transfusional strategies of RBC/fresh plasma/platelets (1:1:1 or 2:1:1) have failed to show any benefit.23 In this case, only 2 units of RBC were needed. Based on the thromboelastography results, no additional blood products were used, neither was the massive transfusion protocol activated.

The use of vasopressors such as norepinephrine fails to treat the underlying cause of the hypovolemic shock and reduce the peripheral tissue perfusion. The decision to use vasopressors shall be based on the individual patient clinic.

In order to locate the bleeding site, the clinical signs (wheezing, pulmonary aggregates, dullness to percussion) may be unspecific. The use of the bronchoscope which has a larger diameter offers the advantage of a higher suction power and maintenance of the patent airway and hence is the preferred approach in case of proximal airway bleeding, but not in case of peripheral bleeding; hence, the flexible fibrobronchoscope is ideal in this case, but the narrower gauge limits any potential therapeutic intervention and prevents proper suction in massive hemoptysis.16

Positioning the patient on the side of the bleeding lung is intended to prevent the hemorrhage from reaching the healthy lung, which increases the pulmonary shunt and further impairs the ventilation/perfusion ratio. According to the literature reviewed, there are no studies measuring the benefits of such maneuver and the priority shall be to secure the airway.16

Intubation with dual lumen tube is ideal to secure the airway, isolating the bleeding lung and allowing for ventilation of the other lung. Proper positioning shall be done and checked under direct vision but this requires experience and is difficult to accomplish under profuse bleeding in the airway. Furthermore, repeated failed attempts may increase the patient's morbidity and mortality.16,24,25 In this particular case, we were able to intubate with a dual lumen tube on the first attempt. Other options include selective intubation with a standard orotracheal tube or the use of the bronchial blocker.

Timeliness in controlling the bleeding site is of the essence to improve the perioperative outcomes. The fibrobronchoscope enables the visualization of bleeding and if the bleeding is mild it may be controlled with the continuous administration of 50ml of cold water (4°C).26 Another option is the possibility to place a bronchial blocker, although the literature regarding the efficacy thereof is limited and in case of massive bleeding proper positioning of the blocker is quite difficult.16,26–29 Endobronchial techniques using electrical devices (laser, cryotherapy and argon plasma) could be an option for definitive therapy, but the implementation of these techniques could be difficult in massive hemoptysis.30

In our case, it was not possible to perform an arteriogram-based embolization because of the presence of severe vasospasm at the bleeding site (Fig. 2) which is a contraindication. This technique is a diagnostic and therapeutic option of the bleeding site.31,32 Around 90% of massive hemoptysis derive from the bronchial arteries33; selective embolization of these arteries controls bleeding in up to 90% of the cases.34,35

Emergency surgery (lobectomy or segmentectomy) is the last option to control severe hemoptysis. Mortality may be as high as 25%, though it may decrease with smaller resections.36

Finally, we did not use antifibrinolytic therapy (tranexamic acid) to control hemoptysis. The literature is scant, non-comparable, and has a low level of evidence.37 There is not enough evidence to know whether the antifibrinolytic therapy shall be used for the treatment of hemoptysis from any cause, although some trials suggest a shorter duration of bleeding.38

In conclusion, the management of massive hemoptysis shall be multidisciplinary (Anesthesiologist, Interventional Pulmonologist, Thorax Surgeon, and Interventional Radiologist). The three pillars of treatment are based on achieving hemodynamic stability, ensuring adequate ventilation of the healthy lung, and controlling the bleeding site (Fig. 4). Whilst the incidence of this complication is low, it may have fatal consequences and further studies are required for adequate treatment thereof.

Ethical disclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent

The authors declare that no patient data appear in this article.



Conflict of interest

The authors have no conflicts of interest to disclose.

C.A. Pue, E.R. Pacht.
Complications of fiberoptic bronchoscopy at a university hospital.
Chest, 107 (1995), pp. 430-432
F. Jin, D. Mu, D. Chu, E. Fu, Y. Xie, T. Liu.
Severe complications of bronchoscopy.
Respiration, 76 (2008), pp. 429-433
N. Facciolongo, M. Patelli, S. Gasparini, L. Lazzari Agli, M. Salio, C. Simonassi, et al.
Incidence of complications in bronchoscopy. Multicentre prospective study of 20,986 bronchoscopies.
Monaldi Arch Chest Dis, 71 (2009), pp. 8-14
I.M. Carr, C.F. Koegelenberg, F. von Groote-Bidlingmaier, A. Mowlana, K. Silos, T. Haverman, et al.
Blood loss during flexible bronchoscopy: a prospective observational study.
Respiration, 84 (2012), pp. 312-318
M.H. Tukey, R.S. Wiener.
Population-based estimates of transbronchial lung biopsy utilization and complications.
Respir Med, 106 (2012), pp. 1559-1565
D.E. Ost, A. Ernst, X. Lei, K.L. Kovitz, S. Benzaquen, J. Diaz-Mendoza, et al.
Diagnostic yield and complications of bronchoscopy for peripheral lung lesions. Results of the AQuIRE Registry.
Am J Respir Crit Care Med, 193 (2016), pp. 68-77
G.A. Eapen, A.M. Shah, X. Lei, C.A. Jimenez, R.C. Morice, L. Yarmus, et al.
Complications, consequences, and practice patterns of endobronchial ultrasound-guided transbronchial needle aspiration: results of the AQuIRE registry.
Chest, 143 (2013), pp. 1044-1053
R.M. Schnabel, K. van der Velden, A. Osinski, G. Rohde, P.M. Roekaerts, D.C. Bergmans.
Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients.
BMC Pulm Med, 15 (2015), pp. 107
R.A. Dweik, J.K. Stoller.
Role of bronchoscopy in massive hemoptysis.
Clin Chest Med, 20 (1999), pp. 89-105
R. Corey, K.M. Hla.
Major and massive hemoptysis: reassessment of conservative management.
Am J Med Sci, 294 (1987), pp. 301-309
W.H. Ibrahim.
Massive haemoptysis: the definition should be revised.
Eur Respir J, 32 (2008), pp. 1131-1132
L. Sakr, H. Dutau.
Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management.
Respiration, 80 (2010), pp. 38-58
P.A. Flume, J.R. Yankaskas, M. Ebeling, T. Hulsey, L.L. Clark.
Massive hemoptysis in cystic fibrosis.
Chest, 128 (2005), pp. 729-738
T.H. Ong, P. Eng.
Massive hemoptysis requiring intensive care.
Intensive Care Med, 29 (2003), pp. 317-320
A. Valipour, A. Kreuzer, H. Koller, W. Koessler, O.C. Burghuber.
Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis.
Chest, 127 (2005), pp. 2113-2118
S. Yendamuri.
Massive airway hemorrhage.
Thorac Surg Clin, 25 (2015), pp. 255-260
S. Finfer, R. Bellomo, N. Boyce, J. French, J. Myburgh, R. Norton, et al.
A comparison of albumin and saline for fluid resuscitation in the intensive care unit.
N Engl J Med, 350 (2004), pp. 2247-2256
C. Gheorghe, R. Dadu, C. Blot, F. Barrantes, R. Vazquez, F. Berianu, et al.
Hyperchloremic metabolic acidosis following resuscitation of shock.
Chest, 138 (2010), pp. 1521-1522
E. Burdett, A. Dushianthan, E. Bennett-Guerrero, S. Cro, T.J. Gan, M.P. Grocott, et al.
Perioperative buffered versus non-buffered fluid administration for surgery in adults.
Cochrane Database Syst Rev, 12 (2012), pp. CD004089
A.J. Nordin, H. Mäkisalo, K.A. Höckerstedt.
Failure of dobutamine to improve liver oxygenation during resuscitation with a crystalloid solution after experimental haemorrhagic shock.
Eur J Surg, 162 (1996), pp. 973-979
J.V. Llau, F.J. Acosta, G. Escolar, E. Fernández-Mondéjar, E. Guasch, P. Marco, et al.
Multidisciplinary consensus document on the management of massive haemorrhage (HEMOMAS document).
Med Intensiva, 39 (2015), pp. 483-504
H.G. Klein, D.R. Spahn, J.L. Carson.
Red blood cell transfusion in clinical practice.
P.R. Scully.
Major trauma and transfusion in the north east of England.
Injury extra, pp. 208-209
A.A. Garzon, M.M. Cerruti, M.E. Golding.
Exsanguinating hemoptysis.
J Thorac Cardiovasc Surg, 84 (1982), pp. 829-833
A.A. Conlan, S.S. Hurwitz.
Management of massive haemoptysis with the rigid bronchoscope and cold saline lavage.
Thorax, 35 (1980), pp. 901-904
L. Freitag, E. Tekolf, G. Stamatis, M. Montag, D. Greschuchna.
Three years experience with a new balloon catheter for the management of haemoptysis.
Eur Respir J, 7 (1994), pp. 2033-2037
P. Jolliet, P. Soccal, J.C. Chevrolet.
Control of massive hemoptysis by endobronchial tamponade with a pulmonary artery balloon catheter.
Crit Care Med, 20 (1992), pp. 1730-1732
R. Kato, M. Sawafuji, M. Kawamura, K. Kikuchi, K. Kobayashi.
Massive hemoptysis successfully treated by modified bronchoscopic balloon tamponade technique.
Chest, 109 (1996), pp. 842-843
E.C. Saw, L.S. Gottlieb, T. Yokoyama, B.C. Lee.
Flexible fiberoptic bronchoscopy and endobronchial tamponade in the management of massive hemoptysis.
Chest, 70 (1976), pp. 589-591
P. Bhattacharyya, A. Dutta, A.N. Samanta, S.R. Chowdhury.
New procedure: bronchoscopic endobronchial sealing; a new mode of managing hemoptysis.
Chest, 121 (2002), pp. 2066-2069
W. Yoon, J.K. Kim, Y.H. Kim, T.W. Chung, H.K. Kang.
Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review.
Radiographics, 22 (2002), pp. 1395-1409
H.J. Chun, J.Y. Byun, S.S. Yoo, B.G. Choi.
Added benefit of thoracic aortography after transarterial embolization in patients with hemoptysis.
AJR Am J Roentgenol, 180 (2003), pp. 1577-1581
J. Chen, L.A. Chen, Z.X. Liang, C.S. Li, Q. Tian, Z. Yang, et al.
Immediate and long-term results of bronchial artery embolization for hemoptysis due to benign versus malignant pulmonary diseases.
Am J Med Sci, 348 (2014), pp. 204-209
O. Fruchter, S. Schneer, V. Rusanov, A. Belenky, M.R. Kramer.
Bronchial artery embolization for massive hemoptysis: long-term follow-up.
Asian Cardiovasc Thorac Ann, 23 (2015), pp. 55-60
G.R. Alexander.
A retrospective review comparing the treatment outcomes of emergency lung resection for massive haemoptysis with and without preoperative bronchial artery embolization.
Eur J Cardiothorac Surg, 45 (2014), pp. 251-255
C.A. Moen, A. Burrell, J. Dunning.
Does tranexamic acid stop haemoptysis?.
Interact Cardiovasc Thorac Surg, 17 (2013), pp. 991-994
G. Prutsky, J.P. Domecq, C.A. Salazar, R. Accinelli.
Antifibrinolytic therapy to reduce haemoptysis from any cause.
Cochrane Database Syst Rev, (2012), pp. CD008711
M.F. Maguire, C.B. Berry, L. Gellett, R.G. Berrisford.
Catastrophic haemoptysis during rigid bronchoscopy: a discussion of treatment options to salvage patients during catastrophic haemoptysis at rigid bronchoscopy.
Interact Cardiovasc Thorac Surg, 3 (2004), pp. 222-225

Please cite this article as: Segura-Salguero JC, Díaz-Bohada L, Lutz-Peña JR, Posada AM, Ronderos V. Manejo perioperatorio de hemoptisis masiva durante la realización de fibrobroncoscopia: Rev Colomb Anestesiol. 2017;45:256–261.

Copyright © 2017. Sociedad Colombiana de Anestesiología y Reanimación
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos